La chaîne d'options affiche les données clés des options sur actions de Propanc Biopharma à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Propanc Biopharma..

Propanc Biopharma (NASDAQ:PPCB) Stock, Chaîne d'Options

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Propanc Biopharma Inc

News

Financing

Press Releases

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

The Next Wave of Cancer Innovation: How Breakthrough Therapies Are Redefining Treatment Paradigms

Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!

IPOs

Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ

Biotechs Big Bang: IPOs, Uplists and the Short Squeeze Effect

Propanc Biopharma Provides Shareholder Update

AMZN

BNTX

BTAI

COST

GEHC

MRNA

NVDA

PPCB

RHHVF

SANA

SNGX

SNYR

VTAK

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Dyadic International, Inc. - Common Stock

Dyadic International

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroGen

Generation Bio

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma Co

LAVA Therapeutics

Medicus Pharma

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

PepGen

Pluri

Propanc Biopharma

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

RenovoRx

Senti Biosciences

Tharimmune

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Exicure

Xilio Therapeutics

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

XOMA Royalty

8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th

Comments

Propanc Biopharma

Propanc Biopharma (PPCB) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL